Komori
PRISM BioLab (206A) · InitiativeFirst statedLatest Earnings (2026-08-14): "Advanced"

Managing the Number of Programs at Each R&D Stage as a Progress Indicator

First written in FY2025. 4 of 7 entries say "Advanced", first in 2026-05-14. Latest entry: 2026-08-14.

7entries
2years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025Advanced2026-06-15 – 2026-08-142025: 12026: 62026
Same theme, other companies
Making Research and Development Progress an Evaluation Metric for Management GoalsA theme 9 companies write about · 0 as a headwind · 7 as a tailwind

The whole theme swung hardest in 2025: 2 of 8 companies on the "Worse" side.

1 other company's latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  2. FY2025First statedAnnual report

    「We manage the number of programs at each stage of research and development as an indicator of business progress.」

    While the company does not establish target management indicators such as revenue, it stated for the first time that it manages the number of programs at each stage, including target identification, hit compound discovery, lead compound discovery and lead optimization, as indicators of business progress.
Moved together

"Maintaining multiple in-house drug discovery programs and continuously selecting new targets" moved the same way as this thread, in the same document, in 3 of its 5 moves.

322★123
  1. ★This thread
  2. 1Maintaining multiple in-house drug discovery programs and continuously selecting new targets3×
  3. 2Milestone and Royalty Income Through Partnerships with Pharmaceutical Companies2×
  4. 3Expanding PepMetics into established large markets, including kinases and membrane proteins2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for PRISM BioLab yet. It last moved in the Earnings of 2026-08-14: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.